disease

FDA APPROVES NEW COMBINATION VACCINE THAT PROTECTS CHILDREN AGAINST TWO BACTERIAL DISEASES

 
June 22, 2012 (Washington, D.C.) -- The U.S. Food and Drug Administration has approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.